216 related articles for article (PubMed ID: 27821401)
21. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
22. Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis.
Jaguszewski M; Ghadri JR; Seifert B; Hiestand T; Herrera P; Gaemperli O; Landmesser U; Maier W; Nallamothu BK; Windecker S; Lüscher TF; Templin C
J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):220-9. PubMed ID: 24979116
[TBL] [Abstract][Full Text] [Related]
23. First-generation versus second-generation drug-eluting stents in patients with chronic kidney disease: a systematic review and meta-analysis.
Gao WD; Ma M; Zhang GX; Zhang XF; Sun G
Postgrad Med; 2019 Jan; 131(1):43-51. PubMed ID: 30422052
[TBL] [Abstract][Full Text] [Related]
24. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
[TBL] [Abstract][Full Text] [Related]
25. Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction.
Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; Fergus I; King SB
Am J Cardiol; 2011 May; 107(9):1311-8. PubMed ID: 21497210
[TBL] [Abstract][Full Text] [Related]
26. Drug-Eluting vs Bare-Metal Stents in Patients With Chronic Kidney Disease and Coronary Artery Disease: Insights From a Systematic Review and Meta-Analysis.
Volodarskiy A; Kumar S; Pracon R; Sidhu M; Kretov E; Mazurek T; Bockeria O; Kaul U; Bangalore S
J Invasive Cardiol; 2018 Jan; 30(1):10-17. PubMed ID: 28915510
[TBL] [Abstract][Full Text] [Related]
27. Meta-Analysis of Comparison of Drug-Eluting Stents and Bare-Metal Stents in Patients on Dialysis.
Li S; Ye D; Chen G; Xu W
Am J Cardiol; 2017 Apr; 119(8):1186-1192. PubMed ID: 28215414
[TBL] [Abstract][Full Text] [Related]
28. Outcomes with first- versus second-generation drug-eluting stents in coronary chronic total occlusions (CTOs): a systematic review and meta-analysis.
Lanka V; Patel VG; Saeed B; Kotsia A; Christopoulos G; Rangan BV; Mohammad A; Luna M; Garcia S; Abdullah SM; Grodin J; Hastings JL; Banerjee S; Brilakis ES
J Invasive Cardiol; 2014 Jul; 26(7):304-10. PubMed ID: 24993986
[TBL] [Abstract][Full Text] [Related]
29. Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.
Lee MS; Yang T; Kandzari DE; Tobis JM; Liao H; Mahmud E
Am J Cardiol; 2010 Apr; 105(8):1076-82. PubMed ID: 20381656
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of drug-eluting stents versus bare-metal stents in patients with cardiogenic shock complicating acute myocardial infarction.
Chen DY; Mao CT; Tsai ML; Chen SW; Lin YS; Hsieh IC; Hung MJ; Wang CH; Wen MS; Cherng WJ; Chen TH
Int J Cardiol; 2016 Jul; 215():98-104. PubMed ID: 27111168
[TBL] [Abstract][Full Text] [Related]
31. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.
Bangalore S; Toklu B; Amoroso N; Fusaro M; Kumar S; Hannan EL; Faxon DP; Feit F
BMJ; 2013 Nov; 347():f6625. PubMed ID: 24212107
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
Neupane S; Khawaja O; Edla S; Singh H; Othman H; Bossone E; Yamasaki H; Rosman HS; Eggebrecht H; Mehta RH
Catheter Cardiovasc Interv; 2019 Jul; 94(1):98-104. PubMed ID: 30585391
[TBL] [Abstract][Full Text] [Related]
33. Comparison of bare-metal stents and drug-eluting stents in coronary ostial lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry).
Vasaiwala S; Vlachos H; Selzer F; Marroquin O; Mulukutla S; Abbott JD; Williams DO
Am J Cardiol; 2012 Oct; 110(8):1113-8. PubMed ID: 22762712
[TBL] [Abstract][Full Text] [Related]
34. Different drugs in drug-eluting stents for peripheral artery disease: a systematic evaluation and Bayesian meta-analysis.
Chen K; Xu L; Liu X
J Thromb Thrombolysis; 2024 Mar; 57(3):520-530. PubMed ID: 38281227
[TBL] [Abstract][Full Text] [Related]
35. Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry).
Green SM; Selzer F; Mulukutla SR; Tadajweski EJ; Green JA; Wilensky RL; Laskey WK; Cohen HA; Rao SV; Weisbord SD; Lee JS; Reis SE; Kip KE; Kelsey SF; Williams DO; Marroquin OC
Am J Cardiol; 2011 Dec; 108(11):1658-64. PubMed ID: 21890077
[TBL] [Abstract][Full Text] [Related]
36. Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis.
Crimi G; Gritti V; Galiffa VA; Scotti V; Leonardi S; Ferrario M; Ferlini M; De Ferrari GM; Oltrona Visconti L; Klersy C
J Interv Cardiol; 2018 Jun; 31(3):319-329. PubMed ID: 29285790
[TBL] [Abstract][Full Text] [Related]
37. Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature.
Abdel-Latif A; Mukherjee D; Mesgarzadeh P; Ziada KM
Catheter Cardiovasc Interv; 2010 Dec; 76(7):942-8. PubMed ID: 20506492
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials.
Hao PP; Chen YG; Wang XL; Zhang Y
Tex Heart Inst J; 2010; 37(5):516-24. PubMed ID: 20978561
[TBL] [Abstract][Full Text] [Related]
39. The short- and long-term outcomes of percutaneous intervention with drug-eluting stent vs bare-metal stent in saphenous vein graft disease: An updated meta-analysis of all randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Ahmed S; Bachuwa G; Hassan M
Clin Cardiol; 2018 May; 41(5):685-692. PubMed ID: 29749621
[TBL] [Abstract][Full Text] [Related]
40. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
